Latest Development Pipeline News

Acrux Limited has secured a further $0.46 million advance on its FY25 R&D Tax Incentive, bringing total advances to $2.19 million and supporting its pharmaceutical product development and working capital needs.

Bryah Resources has appointed Greg Hill, a seasoned mining and engineering executive, as its new CEO to spearhead project development and unlock shareholder value. Hill’s global experience aligns with Bryah’s strategic ambitions, including advancing its Western Australian assets and exploring new opportunities like the Golden Pike gold project in Canada.

HMC Capital has delayed the Neoen VIC Portfolio acquisition settlement by one month, secured a $200 million mezzanine financing facility, and announced a strategic merger of its renewable energy platforms under new leadership.

Barton Gold Holdings has entered binding terms to acquire the Wudinna Gold Project in South Australia, adding 279,000 ounces of gold resources to its portfolio. The $15 million transaction, largely settled in shares and milestone payments, awaits Cobra Resources shareholder approval.

Brookside Energy has expanded its SWISH Play acreage in Oklahoma's Anadarko Basin by adding a fifth Drilling Spacing Unit, increasing its high-impact drilling inventory by over a quarter. This move strengthens its development pipeline ahead of a planned NYSE listing.

Arena REIT reports a $18 million uplift in portfolio valuation driven by its early learning and healthcare assets, alongside robust occupancy and a growing development pipeline.

Catalyst Metals reports positive infill drilling results at its Trident Gold Project, confirming expected mineralisation and enabling development to commence with first ore targeted in late 2025.

DigiCo Infrastructure REIT has announced a FY25 distribution of 10.90 cents per security, aligning with its initial guidance and reflecting steady income returns for investors.

Noxopharm’s Sofra™ technology has received promising external validation from BioRay Pharmaceutical, confirming its targeted anti-inflammatory potential and broad applicability in autoimmune disease therapies.

Finbar Group has fast-tracked Ronald Chan’s appointment as CEO, aiming to leverage his deep company experience to strengthen its development pipeline and growth strategy.

National Storage REIT has partnered with GIC to invest $228 million in a second tranche of self-storage development assets, reaffirming its FY25 earnings guidance and strategic growth plans.

EVE Health Group has initiated stability testing for its novel oral treatments targeting erectile dysfunction and dysmenorrhea, marking a crucial step toward regulatory approval in Australia. The company also finalizes its acquisition of Nextract, the developer behind these innovative formulations.